Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease

Journal of Pediatrics

Volumn 149, Issue 2, 2006, Pages 237-240

  Egami, Kimiyasu ^a   Muta, Hiromi ^a   Ishii, Masahiro ^b   Suda, Kenji ^a   Sugahara, Yoko ^a   Iemura, Motofumi ^a   Matsuishi, Toyojiro ^a  

^a KURUME UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; SULFONATED IMMUNOGLOBULIN; VENOGLOBULIN IH;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; INFANT; LABORATORY; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THROMBOCYTE COUNT;

ACUTE DISEASE; ALANINE TRANSAMINASE; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PROSPECTIVE STUDIES; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 33746385382     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpeds.2006.03.050     Document Type: Article

References (28)

1. Newburger J.W., Takahashi M., Burns J.C., Beiser A.S., Chung K.J., Duffy C.E., et al. The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315 (1986) 341-347
2. Newburger J.W., Takahashi M., Beiser A.S., Burns J.C., Bastian J., Chung K.J., et al. A single intravenous infusion of gamma-globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med 324 (1991) 1633-1639
3. Sato N., Sugimura T., Akagi T., Yamakawa R., Hashino K., Eto G., et al. Selective high dose gamma-globulin treatment in Kawasaki disease. assessment of clinical aspects and cost effectiveness. Pediatr Int 41 (1999) 1-7
4. Sundel R.P., Burns J.C., Baker A., Beiser A.S., and Newburger J.W. Gamma globulin re-treatment in Kawasaki disease. J Pediatr 123 (1993) 657-659
5. Burns J.C., Capparelli E.V., Brown J.A., Newburger J.W., and Glode M.P. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. Pediatr Infect Dis J 17 (1998) 1144-1148
6. Han R.K., Silverman E.D., Newman A., and McCrindle B.W. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 154 (2000) 694-699
7. Wallace CA, French JW, Kahn SJ, Sherry DD. Initial intravenous gammaglobulin treatment failure in Kawasaki disease. Pediatrics 2000;105(6):E78. Available at: http://www.pediatrics.org/cgi/content/full/105/6/e78.
8. Fukunishi M., Kikkawa M., Hamana K., Onodera T., Matsuzaki K., and Matumoto Y. Prediction of non-response to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. J Pediatr 137 (2000) 172-176
9. Durongpisitkul K., Soongswang J., Laohaprasitiporn D., Nana A., Prachuabmoh C., and Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 24 (2003) 145-148
10. Hsieh K., Weng K., Lin C., Huang T., Lee C., and Huang S. Treatment of acute Kawasaki disease. aspirin's role in the febrile stage revisited. Pediatrics 114 (2004) e689-e693. http://www.pediatrics.org/cgi/doi/10.1542/peds.2004-1037 Available at: URL: http://www.pediatrics.org/cgi/doi/10.1542/peds.2004-1037.
11. The Japan Kawasaki disease research committee. Diagnostic guidelines of Kawasaki disease. 5th revised ed. (2002). http://www.kawasaki-disease.org/diagnostic/index.html Available at: http://www.kawasaki-disease.org/diagnostic/index.html.
12. Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease (1994), Ministry of Health and Welfare, Tokyo, Japan
13. Muta H., Ishii M., Hirose A., Furui J., Sugahara Y., Himeno W., et al. Randomized prospective controlled study of intravenous gamma-globulin products in treatment of Kawasaki disease. [in Japanese]. J Jpn Soc Pediatr 106 (2002) 742-746
14. Moran A.M., Newburger J.W., Sanders S.P., Parness I.A., Spevak P.J., Burns J.C., et al. Abnormal myocardial mechanics in Kawasaki disease. rapid response to gamma-globulin. Am Heart J 139 (2000) 217-223
15. Hashino K., Ishii M., Iemura M., Akagi T., and Kato H. Re-treatment for immune globulin-resistant Kawasaki disease. a comparative study of additional immune globulin and steroid pulse therapy. Pediatr Int 43 (2001) 211-217
16. Metz C.E. Basic principles of ROC analysis. Semin Nucl Med 8 (1978) 283-298
17. Cantor S.B., Sun C.C., Tortolero-Luna G., Richards-Kortum R., and Follen M. A comparison of C/B ratios from studies using receiver operating characteristics curve analysis. J Clin Epidemiol 52 (1999) 885-892
18. Muta H., Ishii M., Egami K., Furui J., Sugahara Y., Akagi T., et al. Early intravenous gamma-globulin treatment for Kawasaki disease. the nationwide surveys in Japan. J Pediatr 144 (2004) 496-499
19. Niwa K., Aotsuka H., Hamada H., Uchishiba M., Terai M., and Niimi H. Thrombocytopenia. a risk factor for acute myocardial infarction during the acute phase of Kawasaki disease. Coron Artery Dis 6 (1995) 857-864
20. Furukawa S., Matsubara T., and Yabuta K. Kawasaki disease. immunological review, and case reports of familial Kawasaki disease and complicated by DIC. [in Japanese]. Riumachi-ka 9 (1993) 165-174
21. Rosenfeld E.A., Corydon K.E., and Shulman S.T. Kawasaki disease in infant less than one year of age. J Pediatr 126 (1995) 524-529
22. Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 33 (1991) 805-810
23. Wright D.A., Newburger J.W., Baker A., and Sundel R.P. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids. J Pediatr 128 (1996) 146-149
24. Imanaga T., Mori M., Miyamae T., Ito S., Nakamura T., Yasui K., et al. Plasma exchange for refractory Kawasaki disease. Eur J Pediatr 163 (2004) 263-264
25. Burns J.C., Mason W.H., Hauger S.B., Janai H., Bastian J.F., Wohrley J.D., et al. Infliximab treatment for refractory Kawasaki syndrome. J Pediatr 146 (2005) 662-667
26. Shinohara M., Sone K., Tomomasa T., and Morikawa A. Corticosteroids in the treatment of the acute phase of Kawasaki disease. J Pediatr 135 (1999) 465-469
27. Sundel R.P., Baker A.L., Fulton D.R., and Newburger J.W. Corticosteroids in the initial treatment of Kawasaki disease. report of a randomized trial. J Pediatr 142 (2003) 611-616
28. de Zorzi A., Coran S.D., Gauvreau K., Baker A.L., Sundel R., and Newburger J.W. Coronary artery dimensions may be misclassified as normal in Kawasaki disease. J Pediatr 133 (1998) 254-258